|
E. K. Afenya
and C. Calderón
, Diverse ideas on the growth kinetics of disseminated cancer cells, Bull. Math. Biol., 62 (2000)
, 527-542.
doi: 10.1006/bulm.1999.0165.
|
|
P. Bonate, Pharmacokinetic and Pharmacodynamic Modeling and Simulation 2nd Ed., Springer, New York, NY, 2011.
|
|
B. Bonnard and M. Chyba, Singular Trajectories and their Role in Control Theory, Springer, Series: Mathematics and Applications, Vol. 40,2003.
|
|
A. Bressan and B. Piccoli, Introduction to the Mathematical Theory of Control, American Institute of Mathematical Sciences, 2007.
|
|
G. E. Briggs
and J. B. Haldane
, A note on the kinetics of enzyme action, Biochem. J., 19 (1925)
, 338-339.
doi: 10.1042/bj0190338.
|
|
B. Chereda
and J. V. Melo
, Natural course and biology of CML, Ann. Hematol., 94 (2015)
, 107-121.
doi: 10.1007/s00277-015-2325-z.
|
|
H. Derendorf
and B. Meibohm
, Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives, Pharm. Res., 16 (1999)
, 176-185.
|
|
S. Faderl
, M. Talpaz
, Z. Estrov
, S. O'Brien
, R. Kurzrock
and H. Kantarjian
, The biology of chronic myeloid leukemia, New England J. of Medicine, 341 (1999)
, 164-172.
doi: 10.1056/NEJM199907153410306.
|
|
A. Källén, Computational Pharmacokinetics, Chapman and Hall, CRC, London, 2007.
|
|
U. Ledzewicz
and H. Moore
, Dynamical systems properties of a mathematical model for treatment of CML, Applied Sciences, 6 (2016)
, p291.
doi: 10.3390/app6100291.
|
|
P. Macheras and A. Iliadin, Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics Interdisciplinary Applied Mathematics, Vol. 30, 2nd ed., Springer, New York, 2016.
doi: 10.1007/978-3-319-27598-7.
|
|
L. Michaelis
and M. L. Menten
, Die kinetik der invertinwirkung, Biochem. Zeitschrift, 49 (1913)
, 333-369.
|
|
H. Moore, L. Strauss and U. Ledzewicz, Mathematical optimization of combination therapy for chronic myeloid leukemia (CML), A poster presented at the 6th American Conference on Pharmacometrics, Crystal City, VA, October 4-7,2015.
|
|
A. Nakamura-Ishizu
, H. Takizawa
and T. Suda
, The analysis, roles and regulation of quiescence in hematopoietic stem cells, Development, 141 (2014)
, 4656-4666.
doi: 10.1242/dev.106575.
|
|
L. S. Pontryagin, V. G. Boltyanskii, R. V. Gamkrelidze and E. F. Mishchenko, The Mathematical Theory of Optimal Processes, MacMillan, New York, 1964.
|
|
M. Rowland and T. N. Tozer, Clinical Pharmacokinetics and Pharmacodynamics, Wolters Kluwer Lippicott, Philadelphia, 1995.
|
|
C. L. Sawyers
, Chronic myeloid leukemia, New England J. of Medicine, 340 (1999)
, 1330-1340.
doi: 10.1056/NEJM199904293401706.
|
|
H. Schättler and U. Ledzewicz, Geometric Optimal Control: Theory, Methods and Examples Springer Verlag, 2012.
doi: 10.1007/978-1-4614-3834-2.
|
|
H. Schättler and U. Ledzewicz, Optimal Control for Mathematical Models of Cancer Therapies Springer Verlag, 2015.
doi: 10.1007/978-1-4939-2972-6.
|